Cargando…

Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome

OBJECTIVE: To explore whether elevated anti-Müllerian hormone (AMH) levels affect the rate of preterm birth (PTB) among PCOS patients with different BMIs. METHODS: In this retrospective cohort study, patients with PCOS who had undergone IVF/ICSI from January 2017 to December 2019 were included for p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Mingze, Zhang, Junwei, Yu, Xiaona, Guan, Yichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692368/ https://www.ncbi.nlm.nih.gov/pubmed/34956097 http://dx.doi.org/10.3389/fendo.2021.788000

Ejemplares similares

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study
por: Li, Zhen, et al.
Publicado: (2022)

Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study
por: Guan, Yichun, et al.
Publicado: (2022)

Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis
por: Zhang, Junwei, et al.
Publicado: (2023)

Endometrial Thickness Is a Risk Factor for Singleton Low Birth Weight From Single Blastocyst Transfer: A Retrospective Cohort Study
por: Du, Mingze, et al.
Publicado: (2021)

Season and temperature do not affect cumulative live birth rate and time to live birth in in vitro fertilization
por: Du, Mingze, et al.
Publicado: (2023)

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome
por: Su, Nianjun, et al.
Publicado: (2023)

OR35-04 Anti-Müllerian Hormone Variants identified in Patients with Polycystic Ovary Syndrome Affect Secretion and Immunoactivity
por: Meng, Li, et al.
Publicado: (2023)

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis
por: Du, Mingze, et al.
Publicado: (2021)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
por: Tata, Brooke, et al.
Publicado: (2018)

Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies
por: Zhou, Siyu, et al.
Publicado: (2021)

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study
por: Du, Mingze, et al.
Publicado: (2023)

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
por: Abbara, Ali, et al.
Publicado: (2019)

Comparison of Pregnancy and Neonatal Outcomes of Single Frozen Blastocyst Transfer Between Letrozole-Induction and HRT Cycles in Patients With Abnormal Ovulation
por: Zhang, Junwei, et al.
Publicado: (2021)

Effect of serum progesterone levels on hCG trigger day on pregnancy outcomes in GnRH antagonist cycles
por: Zhang, Junwei, et al.
Publicado: (2022)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
por: Yu, Jin, et al.
Publicado: (2023)

SAT-258 Anti-Mullerian Hormone (AMH) Levels Reflect Ovarian Follicle Count by MRI but Not Ovarian Size in Young Patients with Polycystic Ovary Syndrome
por: Pereira-Eshraghi, Camila, et al.
Publicado: (2019)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran, Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

Clinical and Neonatal Outcomes of Children Born After ICSI With or Without Surgically Acquired Sperm: A Retrospective Cohort Study
por: Du, Mingze, et al.
Publicado: (2022)

The duration of estrogen treatment before progesterone application does not affect neonatal and perinatal outcomes in frozen embryo transfer cycles
por: Zhang, Junwei, et al.
Publicado: (2023)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
por: Du, Juan, et al.
Publicado: (2021)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
por: Peng, Yuanyuan, et al.
Publicado: (2022)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions
por: Emanuel, Rebecca H. K., et al.
Publicado: (2022)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
por: Hestiantoro, Andon, et al.
Publicado: (2016)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57ij3ufn6b30oes3a6cbik2lem